X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with GSK Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs GSK PHARMA - Comparison Results

GSK PHARMA 
   Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE GSK PHARMA TTK HEALTHCARE/
GSK PHARMA
 
P/E (TTM) x 19.3 53.5 36.1% View Chart
P/BV x 2.3 10.6 21.4% View Chart
Dividend Yield % 0.7 2.7 27.0%  

Financials

 TTK HEALTHCARE   GSK PHARMA
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-18
GSK PHARMA
Mar-18
TTK HEALTHCARE/
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs1,4582,760 52.8%   
Low Rs7952,040 39.0%   
Sales per share (Unadj.) Rs408.7339.0 120.6%  
Earnings per share (Unadj.) Rs12.941.4 31.0%  
Cash flow per share (Unadj.) Rs23.645.9 51.5%  
Dividends per share (Unadj.) Rs5.0035.00 14.3%  
Dividend yield (eoy) %0.41.5 30.4%  
Book value per share (Unadj.) Rs164.9242.9 67.9%  
Shares outstanding (eoy) m14.1384.70 16.7%   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x2.87.1 38.9%   
Avg P/E ratio x87.657.9 151.2%  
P/CF ratio (eoy) x47.652.3 91.1%  
Price / Book Value ratio x6.89.9 69.1%  
Dividend payout %38.984.5 46.0%   
Avg Mkt Cap Rs m15,916203,280 7.8%   
No. of employees `0002.2NA-   
Total wages/salary Rs m1,0905,234 20.8%   
Avg. sales/employee Rs Th2,573.8NM-  
Avg. wages/employee Rs Th485.7NM-  
Avg. net profit/employee Rs Th81.0NM-  
INCOME DATA
Net Sales Rs m5,77628,715 20.1%  
Other income Rs m76545 13.9%   
Total revenues Rs m5,85129,260 20.0%   
Gross profit Rs m4265,059 8.4%  
Depreciation Rs m152380 40.1%   
Interest Rs m472 2,365.0%   
Profit before tax Rs m3025,222 5.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0178 0.0%   
Tax Rs m1201,892 6.3%   
Profit after tax Rs m1823,508 5.2%  
Gross profit margin %7.417.6 41.8%  
Effective tax rate %39.736.2 109.7%   
Net profit margin %3.112.2 25.8%  
BALANCE SHEET DATA
Current assets Rs m2,55621,815 11.7%   
Current liabilities Rs m1,67515,999 10.5%   
Net working cap to sales %15.320.3 75.3%  
Current ratio x1.51.4 111.9%  
Inventory Days Days3364 52.6%  
Debtors Days Days3519 187.2%  
Net fixed assets Rs m1,10312,475 8.8%   
Share capital Rs m141847 16.7%   
"Free" reserves Rs m2,18819,726 11.1%   
Net worth Rs m2,33020,573 11.3%   
Long term debt Rs m76 110.0%   
Total assets Rs m4,07339,475 10.3%  
Interest coverage x7.42,612.0 0.3%   
Debt to equity ratio x00 971.4%  
Sales to assets ratio x1.40.7 194.9%   
Return on assets %5.68.9 63.2%  
Return on equity %7.817.1 45.7%  
Return on capital %14.926.2 56.9%  
Exports to sales %3.00-   
Imports to sales %0.60-   
Exports (fob) Rs m172NA-   
Imports (cif) Rs m35NA-   
Fx inflow Rs m172564 30.5%   
Fx outflow Rs m557,429 0.7%   
Net fx Rs m117-6,865 -1.7%   
CASH FLOW
From Operations Rs m2534,728 5.4%  
From Investments Rs m-226-1,042 21.7%  
From Financial Activity Rs m-72-3,066 2.3%  
Net Cashflow Rs m-41620 -6.6%  

Share Holding

Indian Promoters % 65.4 0.0 -  
Foreign collaborators % 0.0 50.7 -  
Indian inst/Mut Fund % 3.7 10.2 36.3%  
FIIs % 5.2 23.8 21.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 15.4 167.5%  
Shareholders   12,723 102,036 12.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   SUN PHARMA  DR. REDDYS LAB  ABBOTT INDIA  UNICHEM LAB  MERCK  

Compare TTK HEALTHCARE With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Elections or Game of Thrones: What Excites You More?(Podcast)

As the TV war in Game of Thrones is set to conclude, we in India, are amidst our own battle for power - the 2019 Elections.

Related Views on News

TTK HEALTHCARE 2017-18 Annual Report Analysis (Annual Result Update)

Mar 27, 2019 | Updated on Mar 27, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

GSK PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 26.0% (Quarterly Result Update)

Feb 5, 2019 | Updated on Feb 5, 2019

For the quarter ended December 2018, GSK PHARMA has posted a net profit of Rs 1 bn (up 26.0% YoY). Sales on the other hand came in at Rs 8 bn (up 17.3% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 60.1% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, TTK HEALTHCARE has posted a net profit of Rs 49 m (down 60.1% YoY). Sales on the other hand came in at Rs 1 bn (up 2.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (2QFY19); Net Profit Down 15.3% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, TTK HEALTHCARE has posted a net profit of Rs 67 m (down 15.3% YoY). Sales on the other hand came in at Rs 2 bn (up 16.3% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

GSK PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 22.7% (Quarterly Result Update)

Oct 23, 2018 | Updated on Oct 23, 2018

For the quarter ended September 2018, GSK PHARMA has posted a net profit of Rs 1 bn (down 22.7% YoY). Sales on the other hand came in at Rs 8 bn (down 2.4% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

More Views on News

Most Popular

My Master Series on How to Trade Election 2019(Profit Hunter)

Apr 16, 2019

For 30 years he has watched how elections impact the markets, and practiced how to profit from it. Now he is here...telling you everything. Read on...

Election Series: Follow the World's Biggest Traders To See Where the Money Flows(The 5 Minute Wrapup)

Apr 17, 2019

20% of all the traders bring in 80% of the money. Watch these 20% and you get a working idea of which way the wind is blowing.

The Best Trading Strategy in the World(Profit Hunter)

Apr 15, 2019

It's our great pleasure to introduce Vijay Bhambwani to our readers - we consider Vijay to be India's best trader. Read on to find out why...

A Letter to You from India's No. 1 Trader(The 5 Minute Wrapup)

Apr 15, 2019

It's our great pleasure to introduce Vijay Bhambwani to our readers - we consider Vijay to be India's best trader. Read on to find out why...

Election Series: Why 'Liquor' is so Important to the Elections(The 5 Minute Wrapup)

Apr 19, 2019

When elections come around, liquor flows like water and everyone gets drunk with power...what does this mean for liquor stocks? Read one to find out from our very own election trading analyst, Vijay Bhambwani.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Apr 26, 2019 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE - LUPIN COMPARISON

COMPARE TTK HEALTHCARE WITH

MARKET STATS